An announcement made by the U.S. Department of State-President’s Emergency Plan for AIDS Relief (PEPFAR) to bring U.S.-based Gilead Sciences’...
NAC JOINS LAUNCH OF FOUR STRATEGIC GENDER DOCUMENTS
The Ministry of Gender, Community Development and Social Welfare has launched four strategic documents aimed at providing a strong policy...
THE MALAWI HIV AND AIDS PARTNERSHIP FORUM (MPF) MEMBERS GATHERED IN LILONGWE TO DISCUSS TOPICAL ISSUES ON NATIONAL RESPONSE TO HIV AND AIDS
The 71st meeting of the Malawi HIV and AIDS Partnership Forum (MPF) was held on August 20th, 2024, in the...
From Relief to Resilience! NAC Advocates for Sustainable, African-Focused Health Systems
At the Africa’s Roadmap to Self-Reliant Healthcare Webinar on August 27, 2025, Dr. Beatrice Matanje, CEO of the National AIDS...
NATIONAL AIDS COMMISSION HOLDS HIGH-LEVEL MEDIA ENGAGEMENT TO SHARE LATEST INFORMATION ON HIV AND AIDS AND ADDRESS MEDIA CONCERNS
In its quest to improve working relationship with the media, the National AIDS Commission (NAC) on Tuesday August 22, 2025,...
NAC CALLS FOR MULTISECTORAL UNITY IN MOBILIZING DOMESTIC FINANCING OF THE NATIONAL HIV AND AIDS RESPONSE
Let’s join hands to mobilize domestic funding towards national response to HIV and AIDS programming amidst dwindling global resources for...
Exciting News! Malawi hits the 95:95:95 HIV Targets ahead of the Deadline
Exciting news to share! Over the years, Malawi has registered remarkable strides in the fight against HIV and AIDS since...
Malawi Leverages South-to-South Learning Network to Reimagine HIV Prevention
Malawi’s HIV prevention champions have gathered at the Bingu International Convention Centre (BICC) in Lilongwe from July 17–18, 2025 to...
The Global Fund Secures Access to Breakthrough HIV Prevention Drug Lenacapavir for Low-and Middle-Income Countries.

Malawi National AIDS Commissions joins global experts in describing this as a pivotal moment on the road to ending AIDS...
HIV Long term injectable drug approved! The National AIDS Commission appeals for continued adherence to present PrEP.

Exciting news! The United States Food and Drug Administration (FDA) has approved an injectable drug for HIV prevention called Lenacapavir...